Abstract:IntroductionDeath association protein-3 (DAP3) was discovered as a responsive protein to interferon-gamma induced cell death and may exert this regulation by interacting with DELE1 (DAP3 Binding Cell Death Enhancer 1) (also known as KIAA0141), a newly discovered mitochondrial stress protein in response to cell stress signals. Whilst DAP3 has been shown to be aberrantly expressed in a limited number of solid tumours, eg. breast cancer and in haematological malignancies (leukaemia), little is known about the relationship between DAP3 and DELE1 in other solid cancers. The present study examined the expression levels of both DAP3 and in DELE1 in colorectal cancers.MethodsA cohort of colorectal tissues from ninety four patients were collected after surgery. Gene transcript levels of both DAP3 and DELE1 were quantitatively assessed by real time polymerase chain reaction. DAP3 and DELE1 proteins in normal colon and tumour tissues were evaluated by immunohistochemistry on tissue arrays. Patients’ clinical, pathological and outcome information were collected and evaluated against gene expression levels.ResultsColorectal tumours had significantly higher levels of DAP3 than normal colon tissues (p<0.001) but DELE1 did not show a difference between tumour and normal tissues. Levels of DAP3 and DELE1 had significant association with disease free survival (p<0.001 and p=0.043) and overall survival (p=0.006 and p=0.068 respectively). Levels of both DAP3 and DELE1 were seen to markedly differ between patients who developed recurrence from those who did not. Kaplan Meier models showed a significant difference for both DAP3 and DELE1 in time to recurrence. Neither DAP3 nor DELE1 had differing levels in tumours with or without lymph node involvement. An interesting feature of the expression pattern of both DAP3 and DELE1 was that they significantly correlated in normal colorectal tissues (r=0.732, p<0.0001) but the correlation of expression was not seen in tumour tissues (p<0.05). Collectively, DAP3 (p=0.002) and DELE1 (p=0.01), together with T staging (p=0.024) are independent prognostic indicators for the overall survival of the patients. DAP3 (p=0.001), together with TNM staging (p=0.003), Dukes staging (p=0.026) and Nodal status (p=0.024) are also independent predictors of the disease free survival of patients.ConclusionDeath associated protein DAP3 and its binding protein DELE1 are highly aberrant in colorectal cancers and are prognostic factors for patients’ clinical outcomes including overall and disease free survival and indicators for local recurrence.

Dap3 and the dap3 binding cell death enhancer-1 (dele1) in human colorectal cancer

Death Associated Protein‑3 (DAP3) and DAP3 Binding Cell Death Enhancer‑1 (DELE1) in Human Colorectal Cancer, and Their Impacts on Clinical Outcome and Chemoresistance

Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell death

Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer

Death-associated Protein-3, DAP-3, Correlates with Preoperative Chemotherapy Effectiveness and Prognosis of Gastric Cancer Patients Following Perioperative Chemotherapy and Radical Gastrectomy.

Effects of the Knockdown of Death-Associated Protein 3 Expression on Cell Adhesion, Growth and Migration in Breast Cancer Cells.

Death-associated protein 3 in cancer—discrepant roles of DAP3 in tumours and molecular mechanisms

Expression of DEK in Pancreatic Cancer and Its Correlation with Clinicopathological Features and Prognosis

Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer

Apobec3g Expression is Correlated with Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Abstract A003: DPEP1 maintains microsatellite stability in colorectal cancer at the tumor microenvironment interface

DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression

DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma

Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer

DAPK1 as an independent prognostic marker in liver cancer

Data from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer

Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.

DAP1 high expression increases risk of lymph node metastases in squamous cell carcinoma of the oral cavity

Expression and Clinicopathological Implication of DcR3 in Lung Cancer Tissues: a Tissue Microarray Study with 365 Cases.